0,955  0,003  Eye irritation, high
0,944  0,003  Skin irritative effect
0,905  0,003  GST A substrate
0,850  0,003  Cholesterol antagonist
0,826  0,005  Carcinogenic
0,820  0,007  TNF expression inhibitor
0,801  0,006  Antihypercholesterolemic
0,793  0,004  Antithrombotic
0,792  0,005  Lipoprotein disorders treatment
0,799  0,015  Antiinflammatory
0,783  0,014  Caspase 9 stimulant
0,771  0,004  Platelet antagonist
0,756  0,004  Vasodilator, peripheral
0,745  0,004  Platelet aggregation inhibitor
0,745  0,008  Respiratory analeptic
0,739  0,004  Antiglaucomic
0,729  0,009  Radioprotector
0,733  0,014  Teratogen
0,715  0,006  Atherosclerosis treatment
0,708  0,003  Antipruritic, allergic
0,708  0,004  Ulceration
0,715  0,014  Embryotoxic
0,701  0,005  Hypolipemic
0,679  0,002  Antihyperlipoproteinemic
0,679  0,009  Analeptic
0,674  0,005  Cardioprotectant
0,674  0,007  NOS3 expression inhibitor
0,671  0,005  Histamine release inhibitor
0,667  0,005  Antipyretic
0,649  0,003  Mediator release inhibitor
0,642  0,003  GST P1-1 substrate
0,639  0,006  Apoptosis antagonist
0,641  0,008  Immunomodulator
0,667  0,036  Apoptosis agonist
0,634  0,012  Mutagenic
0,622  0,005  Antihypertriglyceridemic
0,629  0,023  Cyclophilin D inhibitor
0,629  0,023  Antidiabetic
0,616  0,010  Hepatic disorders treatment
0,607  0,004  Muscular dystrophy treatment
0,613  0,012  Spasmolytic
0,606  0,005  Vasodilator
0,595  0,003  Protein kinase stimulant
0,594  0,004  Phospholipase C inhibitor
0,587  0,009  Hypoglycemic
0,574  0,001  Endocannabinoid uptake inhibitor
0,576  0,005  Antidiabetic symptomatic
0,575  0,003  Phospholipase A2 inhibitor
0,588  0,018  Immunostimulant
0,574  0,005  Myocardial infarction treatment
0,564  0,005  Antiulcerative
0,561  0,005  Non-steroidal antiinflammatory agent
0,558  0,002  Toll-Like receptor 2 antagonist
0,571  0,018  Antiallergic
0,558  0,006  Hair growth stimulant
0,564  0,017  Stroke treatment
0,548  0,013  Antidiabetic (type 2)
0,530  0,005  Radiosensitizer
0,533  0,008  Antihypoxic
0,533  0,010  Angiogenesis stimulant
0,539  0,023  Immunosuppressant
0,520  0,005  Platelet adhesion inhibitor
0,522  0,008  UGT2B4 substrate
0,519  0,015  Antiparasitic
0,511  0,008  Interleukin agonist
0,519  0,017  FMO1 substrate
0,515  0,016  Antihypertensive
0,495  0,004  GST M1-1 substrate
0,509  0,020  Antifungal
0,489  0,004  Aldehyde dehydrogenase inhibitor
0,488  0,005  VCAM1 expression inhibitor
0,483  0,003  Antipruritic, non-allergic
0,502  0,022  Chemoprotective
0,486  0,007  Diabetic retinopathy treatment
0,499  0,021  Antipsoriatic
0,488  0,012  RNA-directed DNA polymerase inhibitor
0,478  0,003  Antihelmintic (Nematodes)
0,480  0,005  Skeletal muscle relaxant
0,476  0,005  Acaricide
0,472  0,001  Lysophosphatidic acid 2 receptor antagonist
0,493  0,025  Cytotoxic
0,480  0,016  Tumour necrosis factor alpha release inhibitor
0,487  0,022  Antiischemic
0,486  0,022  UGT1A9 substrate
0,466  0,003  Vanilloid agonist
0,485  0,024  Sensitization
0,466  0,009  Monophenol monooxygenase inhibitor
0,461  0,008  Abortion inducer
0,503  0,053  Antineoplastic (solid tumors)
0,458  0,009  Carcinogenic, group 3
0,451  0,004  Corneal wound healing stimulator
0,457  0,013  Antimutagenic
0,452  0,014  Sedative
0,444  0,010  Hepatoprotectant
0,453  0,022  ICAM1 expression inhibitor
0,444  0,016  Vascular (periferal) disease treatment
0,451  0,026  Antioxidant
0,444  0,024  Chemopreventive
0,444  0,025  NOS2 expression inhibitor
0,422  0,005  Insulin sensitizer
0,450  0,036  5 Hydroxytryptamine release stimulant
0,431  0,018  DNA synthesis inhibitor
0,416  0,004  Retinoprotector
0,424  0,013  Septic shock treatment
0,434  0,024  Proliferative diseases treatment
0,460  0,051  Transcription factor NF kappa B inhibitor
0,410  0,007  Alkylator
0,415  0,016  Wound healing agent
0,411  0,013  Muscle relaxant
0,407  0,012  Antiseptic
0,409  0,015  Antihelmintic
0,420  0,026  Antiprotozoal (Leishmania)
0,394  0,004  Antieczematic
0,424  0,037  Caspase 3 stimulant
0,409  0,025  Huntington's disease treatment
0,414  0,031  Vasodilator, coronary
0,386  0,007  DNA polymerase I inhibitor
0,387  0,008  Antiparkinsonian, tremor relieving
0,429  0,054  CYP2C9 substrate
0,387  0,012  Anesthetic
0,378  0,006  Gastrin inhibitor
0,392  0,021  Transcription factor STAT inhibitor
0,376  0,007  Glutathione S-transferase substrate
0,379  0,014  UGT2B7 substrate
0,386  0,022  Transcription factor STAT3 inhibitor
0,404  0,040  CYP2C19 substrate
0,387  0,027  UGT1A6 substrate
0,411  0,056  Toll-Like receptor agonist
0,390  0,039  CTGF expression inhibitor
0,414  0,070  5 Hydroxytryptamine release inhibitor
0,347  0,004  Vanilloid 1 agonist
0,368  0,028  Psychostimulant
0,359  0,021  UGT1A4 substrate
0,358  0,023  Anesthetic general
0,355  0,023  Antiparkinsonian, rigidity relieving
0,367  0,035  Cardiotonic
0,369  0,038  Interleukin 2 agonist
0,332  0,005  Adenylate kinase inhibitor
0,335  0,008  Cell adhesion inhibitor
0,328  0,004  Transcription factor NF kappa B stimulant
0,329  0,005  Catenin beta inhibitor
0,327  0,004  UGT2B10 substrate
0,366  0,046  Lipoxygenase inhibitor
0,341  0,022  P-glycoprotein inhibitor
0,352  0,034  Amyotrophic lateral sclerosis treatment
0,319  0,004  Myasthenia Gravis treatment
0,404  0,091  Antiarthritic
0,382  0,070  GABA C receptor rho-3 antagonist
0,312  0,001  Lysophosphatidic acid 3 receptor antagonist
0,318  0,008  Interleukin 4 antagonist
0,350  0,041  DNA damaging
0,309  0,000  Lysophosphatidic acid receptor 3 agonist
0,370  0,063  Inflammatory Bowel disease treatment
0,310  0,005  Alcohol dehydrogenase substrate
0,374  0,070  CYP3A4 substrate
0,321  0,019  Antiacne
0,300  0,001  Lysophosphatidic acid receptor 1 agonist
0,317  0,019  UGT1A3 substrate
0,304  0,007  Antibacterial (Helicobacter pylori)
0,328  0,030  Antiarrhythmic
0,299  0,003  Oleamide hydrolase inhibitor
0,305  0,016  Alpha-N-acetylglucosaminidase inhibitor
0,300  0,013  Acute respiratory distress syndrome (ARDS) treatment
0,291  0,004  Amidase inhibitor
0,374  0,089  Antibacterial
0,327  0,044  Cardiodepressant
0,304  0,021  Melanin inhibitor
0,290  0,008  Toll-Like receptor antagonist
0,348  0,066  Bone diseases treatment
0,292  0,012  Succinate dehydrogenase inhibitor
0,309  0,029  Tyrosine 3 hydroxylase inhibitor
0,282  0,003  Restless leg syndrome treatment
0,281  0,002  Prostaglandin agonist
0,293  0,016  Antidote
0,338  0,062  AR expression inhibitor
0,289  0,015  Antineoplastic antimetabolite
0,277  0,006  Calcium antagonist
0,275  0,003  Arachidonic acid antagonist
0,278  0,010  Neuropathy treatment
0,307  0,039  Nitric oxide antagonist
0,314  0,047  Cardiovascular analeptic
0,282  0,024  CYP2B6 inhibitor
0,307  0,050  Free radical scavenger
0,265  0,010  Antiviral (Poxvirus)
0,266  0,012  Uterine stimulant
0,317  0,064  Sodium/bile acid cotransporter inhibitor
0,269  0,016  Anesthetic local
0,260  0,008  Antiviral (CMV)
0,270  0,019  Antipruritic
0,253  0,004  Toll-Like receptor 2 agonist
0,254  0,006  Gastric antisecretory
0,270  0,023  Skin whitener
0,251  0,005  Actinic keratosis treatment
0,251  0,007  Antirickettsial
0,244  0,002  Antiviral (Parainfluenza)
0,250  0,009  Choleretic
0,250  0,009  Microtubule formation inhibitor
0,306  0,065  Aldehyde oxidase inhibitor
0,262  0,024  Lipid peroxidase inhibitor
0,288  0,052  5 Hydroxytryptamine uptake stimulant
0,239  0,003  Prostaglandin F2 alpha antagonist
0,238  0,008  Aldehyde dehydrogenase substrate
0,285  0,055  Cytostatic
0,249  0,021  Antidiabetic (type 1)
0,231  0,004  Lanosterol 14 alpha demethylase inhibitor
0,267  0,040  DNA methyltransferase I inhibitor
0,235  0,010  Catalase inhibitor
0,265  0,042  UGT1A1 substrate
0,296  0,074  Antiepileptic
0,252  0,031  Antiviral (Herpes)
0,239  0,020  Carcinogenic, group 1
0,224  0,006  Sphingomyelinase inhibitor
0,226  0,008  Antimetabolite
0,224  0,006  Adenylate cyclase stimulant
0,221  0,006  Thioredoxin inhibitor
0,218  0,004  Peroxisome proliferator-activated receptor alpha agonist
0,218  0,005  Leukotriene antagonist
0,217  0,004  Acyl-CoA dehydrogenase inhibitor
0,217  0,006  Prolactin inhibitor
0,218  0,008  Cell adhesion molecule inhibitor
0,256  0,047  UDP-glucuronosyltransferase substrate
0,283  0,074  Antiosteoporotic
0,213  0,006  Peroxisome proliferator-activated receptor gamma agonist
0,219  0,013  UGT2B1 substrate
0,210  0,005  Toll-Like receptor 4 antagonist
0,216  0,012  Coagulant
0,241  0,038  Sepsis treatment
0,254  0,052  Antiviral (HIV)
0,212  0,010  Phosphofructokinase-1 inhibitor
0,243  0,042  Neurotrophic factor enhancer
0,232  0,033  Antiischemic, cerebral
0,202  0,004  Antidote, heavy metal
0,201  0,005  Acetylcholine release stimulant
0,275  0,081  CYP1A2 substrate
0,213  0,019  Raynaud's phenomenon treatment
0,321  0,127  Antiparkinsonian
0,199  0,005  Autotaxin inhibitor
0,197  0,004  Ca2+-transporting ATPase inhibitor
0,208  0,016  Cyclooxygenase 3 inhibitor
0,225  0,034  Interferon gamma antagonist
0,200  0,010  TRPA1 agonist
0,210  0,023  5-Lipoxygenase inhibitor
0,197  0,010  Folate antagonist
0,190  0,003  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,255  0,070  Antineoplastic (liver cancer)
0,212  0,027  Antifungal enhancer
0,196  0,011  Antiviral (Influenza B)
0,270  0,085  FMO3 substrate
0,199  0,014  Antineoplastic, alkylator
0,189  0,005  UGT2B11 substrate
0,218  0,035  Cystic fibrosis treatment
0,222  0,039  Protein-tyrosine phosphatase inhibitor
0,193  0,012  Selectin antagonist
0,212  0,031  Pancreatic disorders treatment
0,214  0,034  Interleukin 6 antagonist
0,210  0,033  Bone formation stimulant
0,207  0,032  Insulin secretagoues
0,182  0,009  Neutropenia treatment
0,202  0,029  Cell wall synthesis inhibitor
0,180  0,008  Prostaglandin EP2 antagonist
0,188  0,016  Mucolytic
0,177  0,006  Ornithine decarboxylase inhibitor
0,176  0,007  Lipase inhibitor
0,184  0,017  Photosensitizer
0,202  0,035  ATPase inhibitor
0,222  0,056  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,195  0,030  Psychosexual dysfunction treatment
0,230  0,065  Anticonvulsant
0,187  0,023  Expectorant
0,175  0,012  Glutamate dehydrogenase inhibitor
0,225  0,063  DNA methylase inhibitor
0,208  0,047  Antiviral (Ebola)
0,240  0,078  Acute neurologic disorders treatment
0,230  0,069  Interleukin antagonist
0,164  0,003  Prostaglandin E2 agonist
0,202  0,044  Amylase inhibitor
0,195  0,037  Genotoxic
0,291  0,134  CYP2C19 inhibitor
0,198  0,041  CNS active muscle relaxant
0,188  0,032  Protein-tyrosine phosphatase 1B inhibitor
0,166  0,011  GST T1-1 substrate
0,159  0,005  Acetyl-CoA transferase inhibitor
0,195  0,042  UGT2B9 substrate
0,164  0,012  Anabolic
0,158  0,005  Anticholelithogenic
0,180  0,027  Antiprotozoal (Amoeba)
0,254  0,104  CYP2D6 substrate
0,225  0,077  Antihypotensive
0,170  0,022  Contraceptive female
0,177  0,029  Hearing loss treatment
0,180  0,032  Cholesterol synthesis inhibitor
0,150  0,004  Vanilloid 2 antagonist
0,181  0,037  Neurotrophic factor
0,164  0,020  Antiviral (Papilloma)
0,211  0,068  Antiviral (Influenza)
0,149  0,008  Glycine transporter 2 inhibitor
0,150  0,010  Interferon agonist
0,143  0,005  Thromboxane antagonist
0,222  0,086  Antiamyloidogenic
0,196  0,061  Diabetic nephropathy treatment
0,159  0,025  HDL-cholesterol increasing
0,151  0,020  Electron transport complex I inhibitor
0,150  0,020  Triose-phosphate isomerase inhibitor
0,214  0,083  Antineoplastic (lymphoma)
0,146  0,016  Paget's disease treatment
0,134  0,004  Thromboxane synthase inhibitor
0,141  0,012  Glutamate release inhibitor
0,132  0,005  Thromboxane A2 antagonist
0,133  0,006  Leukotriene B4 antagonist
0,134  0,009  Elastase 1 inhibitor
0,125  0,002  Lysophosphatidic acid 1 receptor antagonist
0,148  0,025  Transcription factor STAT6 inhibitor
0,164  0,042  Antifungal (Cryptococcus)
0,153  0,031  Sphingosine 1-phosphate receptor 4 antagonist
0,137  0,015  CDC25A inhibitor
0,145  0,023  Antispirochetal
0,260  0,139  Toll-Like receptor 7 agonist
0,138  0,017  Antiviral (Rhinovirus)
0,120  0,002  Prostaglandin EP2 agonist
0,128  0,010  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,121  0,004  Nitric oxide donor
0,119  0,003  Calcium-dependent phospholipase A2 inhibitor
0,120  0,004  Glucose-6-phosphate isomerase inhibitor
0,152  0,036  Menstruation disorders treatment
0,156  0,042  Cathepsin H inhibitor
0,119  0,005  Squalene synthetase inhibitor
0,131  0,016  Antiprotozoal activity enhancer
0,219  0,106  Flavin-containing monooxygenase substrate
0,124  0,012  Glycine receptor agonist
0,124  0,014  Cannabinoid CB1 receptor agonist
0,149  0,039  Gastritis treatment
0,113  0,004  Cholesterol esterase inhibitor
0,114  0,005  Exportin-1 inhibitor
0,115  0,007  Gaucher disease treatment
0,142  0,033  AMP-activated protein kinase stimulant
0,172  0,063  Restenosis treatment
0,180  0,071  Lipocortins synthesis antagonist
0,144  0,036  GABA C receptor agonist
0,122  0,015  Carbamoyl phosphate synthetase inhibitor
0,140  0,033  Carbonic anhydrase III inhibitor
0,149  0,042  Sphingosine 1-phosphate receptor 2 antagonist
0,122  0,016  Sphingosine 1-phosphate receptor 4 agonist
0,110  0,004  Retinoid X receptor agonist
0,107  0,001  Prostaglandin F2 alpha agonist
0,228  0,123  12-Lipoxygenase inhibitor
0,156  0,052  Sphingosine 1-phosphate receptor 5 antagonist
0,235  0,131  Antineoplastic (brain cancer)
0,167  0,063  Diuretic
0,119  0,017  Na+ K+ transporting ATPase inhibitor
0,117  0,016  Ribonucleoside-diphosphate reductase inhibitor
0,175  0,076  Antianginal
0,109  0,010  Antiviral (Herpesvirus 3, Human)
0,175  0,077  Myocardial ischemia treatment
0,102  0,004  Prostaglandin EP4 agonist
0,114  0,018  Ribonucleotide reductase inhibitor
0,197  0,101  Antineoplastic (lymphocytic leukemia)
0,106  0,010  Antimycoplasmal
0,149  0,053  Farnesoid X receptor antagonist
0,169  0,074  Growth hormone agonist
0,114  0,019  Leukotriene synthesis inhibitor
0,126  0,032  Arylamine N-Acetyltransferase substrate
0,099  0,004  Leukotriene C antagonist
0,134  0,040  GABA C receptor antagonist
0,112  0,018  Protein kinase C alpha inhibitor
0,106  0,013  Cannabinoid CB2 receptor antagonist
0,101  0,008  Aconitate hydratase inhibitor
0,157  0,064  UGT2B15 substrate
0,136  0,044  Aminopeptidase B inhibitor
0,105  0,014  Vanilloid 4 agonist
0,114  0,024  Keratolytic
0,140  0,052  Antiviral (Hepatitis B)
0,100  0,012  Interferon inducer
0,165  0,079  Liver fibrosis treatment
0,244  0,159  Antineoplastic (endocrine cancer)
0,151  0,067  Hemostatic
0,089  0,008  Anesthetic inhalation
0,085  0,003  Prostaglandin D2 agonist
0,106  0,026  Glutamate decarboxylase inhibitor
0,120  0,040  GABA C receptor rho-1 antagonist
0,148  0,069  Antiprotozoal (Coccidial)
0,083  0,005  Acetyl-CoA transferase 1 inhibitor
0,090  0,012  Potassium channel intermediate-conductance Ca-activated blocker
0,105  0,027  Antiviral (Hepatitis A)
0,081  0,004  Prostacyclin agonist
0,137  0,060  Antihemorrhagic
0,114  0,039  Tourette's syndrome treatment
0,079  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,126  0,052  Caspase 3 inhibitor
0,269  0,196  Alzheimer's disease treatment
0,126  0,053  Cystathionine beta-synthase inhibitor
0,093  0,020  Peroxisome proliferator-activated receptor gamma antagonist
0,091  0,020  Protease 3C (Human rhinovirus) inhibitor
0,151  0,081  Thrombolytic
0,123  0,052  Excitatory amino acid transporter EAAC1 inhibitor
0,082  0,012  Lipocortins synthesis agonist
0,129  0,059  Growth stimulant
0,089  0,021  Beta adrenoreceptor antagonist
0,071  0,004  Leukotriene C4 antagonist
0,099  0,033  Glycine receptor antagonist
0,088  0,022  Cannabinoid CB1 receptor antagonist
0,111  0,045  Electrolyte absorption antagonist
0,081  0,015  Sphingosine kinase inhibitor
0,125  0,060  Platelet activating factor antagonist
0,087  0,022  Alcohol oxidase inhibitor
0,110  0,045  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,123  0,058  Antifungal (Pneumocystis)
0,235  0,171  Antiobesity
0,095  0,031  Cannabinoid receptor antagonist
0,065  0,002  Carbonic anhydrase VIII inhibitor
0,065  0,002  Carbonic anhydrase X inhibitor
0,239  0,177  CYP2C9 inhibitor
0,086  0,023  Potassium channel (Tandem pore domain) blocker
0,069  0,007  Microtubule stabilization
0,075  0,014  Acetyl-CoA transferase 2 inhibitor
0,073  0,012  Adenosine deaminase inhibitor
0,082  0,022  Glutamate (mGluR6) antagonist
0,101  0,041  Interleukin 5 antagonist
0,103  0,043  Bile acid receptor antagonist
0,098  0,039  Carbonic anhydrase XIII inhibitor
0,080  0,021  Ornithine carbamoyltransferase inhibitor
0,078  0,020  Fatty acid synthase inhibitor
0,090  0,033  Epoxide hydrolase inhibitor
0,061  0,003  Elastase 3B inhibitor
0,061  0,003  Elastase 2B inhibitor
0,061  0,003  Elastase 3A inhibitor
0,075  0,018  Glucosylceramidase inhibitor
0,096  0,040  Hematopoietic
0,092  0,036  Estrogen-related receptor beta agonist
0,098  0,042  ATPase (Vacuolar H+) inhibitor
0,174  0,118  Cyclic AMP phosphodiesterase inhibitor
0,203  0,147  Antimycobacterial
0,083  0,029  Phospholipase D inhibitor
0,158  0,104  Antiviral (Hepatitis)
0,057  0,003  Calcium-independent phospholipase A2 inhibitor
0,246  0,194  DNA directed DNA polymerase inhibitor
0,062  0,009  Membrane dipeptidase inhibitor
0,072  0,020  Sphingosine kinase 2 inhibitor
0,155  0,104  LDLR expression enhancer
0,185  0,135  Superoxide dismutase inhibitor
0,077  0,028  Neuraminidase inhibitor
0,078  0,029  CDC25B inhibitor
0,135  0,087  Antianemic
0,067  0,018  Pregnane X receptor antagonist
0,109  0,062  Ferrochelatase inhibitor
0,229  0,183  15-Lipoxygenase inhibitor
0,103  0,057  UDP-glucose 4-epimerase inhibitor
0,092  0,046  Glutathione S-transferase inhibitor
0,056  0,011  Fumarate hydratase inhibitor
0,054  0,010  Kainate receptor agonist
0,168  0,124  Antineoplastic enhancer
0,053  0,009  Leukotriene D4 antagonist
0,055  0,011  Peroxisome proliferator-activated receptor delta agonist
0,099  0,056  Antifungal (Candida)
0,069  0,027  Beta 1 adrenoreceptor antagonist
0,187  0,145  Antiviral (West Nile virus)
0,115  0,073  Retinopathy treatment
0,045  0,004  Toll-Like receptor 8 agonist
0,089  0,048  Carbonic anhydrase VI inhibitor
0,047  0,009  HMG CoA reductase inhibitor
0,073  0,035  Uterine relaxant
0,080  0,044  Cathepsin G inhibitor
0,134  0,098  GABA C receptor rho-2 antagonist
0,085  0,049  Xanthine oxidase substrate
0,102  0,066  Carcinogenic, group 2B
0,040  0,005  Toll-Like receptor 4 agonist
0,204  0,170  Multiple sclerosis treatment
0,087  0,053  Antineoplastic antibiotic
0,122  0,088  Cytokine production inhibitor
0,053  0,019  Geranyltranstransferase inhibitor
0,109  0,076  Proteasome inhibitor
0,125  0,092  Cyclooxygenase inhibitor
0,069  0,036  Neuraminidase (influenza) inhibitor
0,035  0,003  Thromboxane agonist
0,126  0,094  Peroxidase inhibitor
0,194  0,162  Metabolic disease treatment
0,059  0,028  Alpha-mannosidase inhibitor
0,034  0,003  Thromboxane A2 agonist
0,089  0,058  NADH dehydrogenase inhibitor
0,047  0,017  Factor XIIIa inhibitor
0,104  0,074  SULT1A1 substrate
0,033  0,004  Isoleucine-tRNA ligase inhibitor
0,055  0,026  Squalene epoxidase inhibitor
0,040  0,012  Leukotriene B4 receptor 1 antagonist
0,058  0,032  Adenine nucleotide translocase inhibitor
0,172  0,146  Nitric-oxide synthase stimulant
0,036  0,010  Peroxisome proliferator-activated receptor alpha antagonist
0,113  0,087  Cyclooxygenase 1 inhibitor
0,136  0,111  Antiviral (Hepatitis C)
0,156  0,131  Pneumotoxic
0,028  0,004  Vitamin D receptor agonist
0,049  0,026  Mannosidase inhibitor
0,188  0,165  Antineoplastic (multiple myeloma)
0,077  0,055  Topoisomerase II alpha inhibitor
0,074  0,052  Antibiotic
0,056  0,034  Prostaglandin antagonist
0,123  0,101  SULT1A3 substrate
0,059  0,037  Argininosuccinate synthase inhibitor
0,053  0,032  Beta 2 adrenoreceptor antagonist
0,072  0,051  Aminopeptidase I inhibitor
0,131  0,110  Pulmonary hypertension treatment
0,039  0,018  Prostacyclin antagonist
0,088  0,067  Potassium channel (Ca-activated) activator
0,027  0,007  Calcium-sensing receptor antagonist
0,030  0,009  Elastase 2 inhibitor
0,030  0,009  Elastase 2A inhibitor
0,091  0,073  Protease inhibitor
0,021  0,004  Carbonic anhydrase XI inhibitor
0,074  0,058  Narcotic antagonist
0,086  0,070  Alcohol dehydrogenase inhibitor
0,030  0,014  Prostaglandin H2 antagonist
0,030  0,015  Prostaglandin EP4 antagonist
0,039  0,024  Vanilloid 3 antagonist
0,057  0,043  Sphingosine 1-phosphate receptor 3 antagonist
0,104  0,090  Sphingosine 1-phosphate receptor 2 agonist
0,062  0,047  Cannabinoid receptor agonist
0,127  0,114  Macular degeneration treatment
0,036  0,023  Retinoid X alpha receptor agonist
0,041  0,029  Sphingosine kinase 1 inhibitor
0,025  0,012  Leukotriene B4 receptor 2 antagonist
0,076  0,064  Antidote, organophosphates
0,030  0,018  Hypoxanthine phosphoribosyltransferase inhibitor
0,027  0,015  Vanilloid 2 agonist
0,137  0,126  Aldehyde oxidase substrate
0,016  0,004  Calcineurin inhibitor
0,034  0,023  Sodium-dependent vitamin C transporter 2 inhibitor
0,052  0,042  Carbonic anhydrase VB inhibitor
0,055  0,046  Biliverdin reductase inhibitor
0,030  0,022  Prostaglandin EP3 antagonist
0,038  0,030  GABA uptake inhibitor
0,031  0,023  ATP citrate lysase inhibitor
0,061  0,053  Beta 3 adrenoreceptor antagonist
0,052  0,045  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,040  0,033  Sphingosine 1-phosphate receptor 1 agonist
0,102  0,096  Bipolar disorder treatment
0,046  0,040  Cytokine production stimulant
0,026  0,021  Uridine phosphorylase inhibitor
0,167  0,162  Antineoplastic (pancreatic cancer)
0,017  0,012  G-protein-coupled receptor 120 agonist
0,081  0,076  Tocolytic
0,015  0,011  Purinergic P2Y1 agonist
0,018  0,014  Methylmalonyl-CoA mutase inhibitor
0,079  0,075  Antileprosy
0,020  0,017  Neuraminidase (Influenza B) inhibitor
0,091  0,089  GABA receptor agonist
0,020  0,018  Retinoid X beta receptor antagonist
0,050  0,048  Sphingosine 1-phosphate receptor 5 agonist
0,035  0,033  Retinoid X receptor antagonist
0,063  0,063  Calcium channel L-type blocker
0,010  0,010  Immunosuppressant Cyclosporine-like
0,084  0,083  Xanthine oxidase inhibitor
0,043  0,042  Carbonic anhydrase XIV inhibitor
0,039  0,038  Cholesterol absorption inhibitor
0,083  0,082  Creatine kinase inhibitor

